🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase III randomized open label study designed to compare JDQ443 ...
Status
Active Not Recruiting
Location
Valley Medical Center Research
Start Date
2022-06-15
Trial ID
NCT05132075
The goal of this phase II clinical trial is to evaluate the intracranial ef...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-04-15
Trial ID
NCT05999357
Treatments Being Tested
This study is being done to answer the following question: What are the eff...
Status
Active Not Recruiting
Location
CancerCare Manitoba
Start Date
2023-09-15
Trial ID
NCT05714891
Treatments Being Tested
This is Phase Ib/II, multicenter, open-label adaptive platform study of JDQ...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2022-10-24
Trial ID
NCT05358249
Treatments Being Tested
This is a phase Ib/II open label study. The escalation part will characteri...
Status
Active Not Recruiting
Location
Emory University School of Medicine-Winship Cancer Institute
Start Date
2021-02-24
Trial ID
NCT04699188
Treatments Being Tested
The purpose of this study is to evaluate the effect of hepatic impairment o...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2022-05-03
Trial ID
NCT05329623
Treatments Being Tested
This study aims to evaluate the antitumor activity and safety of JDQ443 sin...
Status
Active Not Recruiting
Location
The Brown University Oncology Group
Start Date
2022-12-06
Trial ID
NCT05445843
Treatments Being Tested
The purpose of this study is to allow continued access to opnurasib (JDQ443...
Status
Recruiting
Location
Novartis Investigative Site
Start Date
2026-06-08
Trial ID
NCT07468071
Treatments Being Tested